These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
711 related articles for article (PubMed ID: 15606348)
1. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926 [TBL] [Abstract][Full Text] [Related]
5. Current status of live attenuated influenza virus vaccine in the US. Belshe RB Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507 [TBL] [Abstract][Full Text] [Related]
6. Live attenuated influenza vaccine in children. Ambrose CS; Walker RE; Connor EM Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372 [TBL] [Abstract][Full Text] [Related]
7. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Ambrose CS; Wu X; Knuf M; Wutzler P Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647 [TBL] [Abstract][Full Text] [Related]
11. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
12. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Mallory RM; Yi T; Ambrose CS Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154 [TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Belshe RB; Gruber WC Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396 [TBL] [Abstract][Full Text] [Related]
15. Duration of protection provided by live attenuated influenza vaccine in children. Ambrose CS; Yi T; Walker RE; Connor EM Pediatr Infect Dis J; 2008 Aug; 27(8):744-8. PubMed ID: 18600188 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363 [TBL] [Abstract][Full Text] [Related]